HHS secretary: recent drug price increases 'creating a tipping point'

The Hill

9 July 2018 - Health and Human Services Secretary Alex Azar on Monday rebuked drug companies for recent price increases.

"Change is coming to prescription drug pricing, whether it’s painful or not for pharmaceutical companies," Azar said in a speech Monday at a health policy conference.

Azar's comments follow Pfizer's decision to raise the list prices of more than 100 prescription drugs.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing